Laumas Sandeep bought UNCY
May 14, 2026 · Form 4 insider transaction
Laumas Sandeep bought 47,941 shares of Unicycive Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 75 days after the transaction.
Direction
Acquired (buy-side)
Shares
47,941
Price
$0.00
Total value
N/A
InsiderLaumas Sandeep
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMay 14, 2026
Filing dateJuly 28, 2026
Shares owned after47,941
OwnershipDirect
10b5-1 planNo
AmendedYes
Footnotes
Represents grant of restricted stock units payable solely in common stock of the Issuer. 19,976 shares vest upon grant and 3,995 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.